Novacea

We are a biopharmaceutical company focused on in-licensing, developing and commercializing novel therapies for the treatment of cancer. We currently have two clinical-stage oncology product candidates. Our lead product candidate, Asentar™ (DN-101), is in a Phase 3 clinical trial for the treatment of androgen-independent prostate cancer, or AIPC, also known as hormone-refractory prostate cancer. Our second product candidate, AQ4N, is being investigated in combination with radiation and chemotherapy in a Phase 1/2 clinical trial of patients with newly diagnosed glioblastoma multiforme. Our highly experienced team uses its expertise in oncology product development to identify, license and develop novel therapeutics with the potential to improve clinical outcomes for cancer patients. We also seek to develop anti-cancer agents that may reduce the toxicities associated with current treatments. In addition, we attempt to mitigate development risks by licensing product candidates with well-characterized mechanisms of action and supportive pre-clinical or clinical data. We believe that our oncology development expertise enables our team to design efficient clinical development and commercialization programs that could provide cancer patients with improved treatment options over current standards of care.

Contact Details: 601 Gateway Blvd., Suite 800 South San Francisco California 94080 United States of America Tel: (650) 228-1800 Fax: (650) 228-1088 Email: info@novacea.com WWW: www.novacea.com/

Loading...

Recent Publications by Novacea:
Selective tumor targeting by the hypoxia-activated prodrug AQ4N blocks tumor growth and metastasis in preclinical models of pancreatic cancer. PURPOSE: The antitumor activities and pharmacokinetics of the...	22nd June, 2007	Novacea, Inc., South San Francisco, California and KuDOS Pharmaceuticals	Clin Cancer Res. 2007 Apr 1;13(7):2216-25. DOI Direct Link

Press Releases on Novacea:
NeurogesX Reports Third Quarter 2009 Results	6th November, 2009	NeurogesX	-- Appointed Bradford S. Goodwin to board as director and Audit Committee chairman Upcoming 2009 Milestones: -- FDA PDUFA date November 16, 2009 for Qutenza NDA to manage pain
New Report Just Published: World Prostate Cancer Therapeutics Market Report	7th July, 2009	Reportlinker	NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Prostate Cancer Therapeutics Market http://www.reportlinker.com/p0119471/World
Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R)	11th June, 2009	Transcept Pharmaceuticals, Inc.	RICHMOND, Calif., June 11 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today that the U.S. Food and Drug Administration (FDA) has informed the company that it
Transcept Pharmaceuticals Presents Data at SLEEP 2009 23rd Annual Meeting of the Associated Professional Sleep Societies	9th June, 2009	Transcept Pharmaceuticals, Inc.	Analyses of Efficacy and Absence of Rebound Effect in a Clinical Study of Intermezzo(R) (Zolpidem Tartrate Sublingual Tablet 3.5 mg) to Treat Middle-of-the-Night (MOTN) Awakening on an As-Needed Basis
Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009	28th May, 2009	Transcept Pharmaceuticals, Inc.	POINT RICHMOND, Calif., May 28 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of

BioNews Results for Novacea:
FDA rejects Transcept sleep drug	East Bay Business Journal:  Oct 29 2009 8:28PM Matching: novacea

Novacea (NOVC) Financial information Links from Barchart
NOVC Quote from from Barchart.com
NOVC Chart from from Barchart.com
NOVC Profile from from Barchart.com
NOVC Opinion from from Barchart.com
→View more Novacea finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 404 times since April 2007, the link to the organisation's website has been followed 89 times

Recent Search Terms used to find this page: novacea pharmaceuticals | novacea pharmaceuticals | novacea pharmaceuticals | novacea | Novacea south san francisco | .

Search for more companies in South San Francisco

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Novacea